Marja Komulainen

1.4k total citations
32 papers, 1.1k citations indexed

About

Marja Komulainen is a scholar working on Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, Marja Komulainen has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Orthopedics and Sports Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Marja Komulainen's work include Bone health and osteoporosis research (17 papers), Vitamin D Research Studies (9 papers) and Estrogen and related hormone effects (9 papers). Marja Komulainen is often cited by papers focused on Bone health and osteoporosis research (17 papers), Vitamin D Research Studies (9 papers) and Estrogen and related hormone effects (9 papers). Marja Komulainen collaborates with scholars based in Finland, Norway and France. Marja Komulainen's co-authors include Seppo Saarikoski, Risto Honkanen, Heikki Kröger, Anna Maria Heikkinen, Marjo Tuppurainen, Leo Niskanen, Esko Alhava, M. Tuppurainen, Pekka H. Mäenpää and Markku Parviainen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Bone and Mineral Research.

In The Last Decade

Marja Komulainen

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marja Komulainen Finland 19 577 362 347 298 235 32 1.1k
Ahmad Hazem United States 9 373 0.6× 342 0.9× 106 0.3× 382 1.3× 150 0.6× 14 1.2k
Lis Stilgren Denmark 17 371 0.6× 243 0.7× 476 1.4× 511 1.7× 282 1.2× 25 1.3k
Osamu Chaki Japan 13 472 0.8× 148 0.4× 172 0.5× 117 0.4× 307 1.3× 22 834
V Pacovský Czechia 16 516 0.9× 187 0.5× 211 0.6× 363 1.2× 386 1.6× 47 1.2k
Alan Hamstra United States 6 423 0.7× 609 1.7× 188 0.5× 136 0.5× 138 0.6× 7 1.0k
Ian Reid New Zealand 4 478 0.8× 221 0.6× 76 0.2× 149 0.5× 184 0.8× 6 738
Raymond Pamphile France 9 320 0.6× 392 1.1× 176 0.5× 62 0.2× 160 0.7× 14 786
Kazuya Makita Japan 17 241 0.4× 153 0.4× 147 0.4× 188 0.6× 152 0.6× 41 664
C. Hasling Denmark 17 406 0.7× 109 0.3× 165 0.5× 150 0.5× 245 1.0× 25 868
Niva Jaccard Israel 9 196 0.3× 341 0.9× 86 0.2× 122 0.4× 89 0.4× 10 609

Countries citing papers authored by Marja Komulainen

Since Specialization
Citations

This map shows the geographic impact of Marja Komulainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja Komulainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja Komulainen more than expected).

Fields of papers citing papers by Marja Komulainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marja Komulainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja Komulainen. The network helps show where Marja Komulainen may publish in the future.

Co-authorship network of co-authors of Marja Komulainen

This figure shows the co-authorship network connecting the top 25 collaborators of Marja Komulainen. A scholar is included among the top collaborators of Marja Komulainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marja Komulainen. Marja Komulainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falandry, Claire, Fanny Pommeret, Laurence Gladieff, et al.. (2022). Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study. The Lancet Healthy Longevity. 3(3). e176–e185. 7 indexed citations
2.
Honkanen, Risto, Heli Koivumaa‐Honkanen, Joonas Sirola, et al.. (2015). Bone loss and wrist fractures after withdrawal of hormone therapy: The 15-year follow-up of the OSTPRE cohort. Maturitas. 85. 49–55. 6 indexed citations
3.
Leminen, Arto, Annika Auranen, Ralf Bützow, et al.. (2012). [Update on current care guidelines: ovarian cancer].. PubMed. 128(12). 1300–1. 3 indexed citations
4.
Sankila, Risto, Arto Leminen, Tapio Kuoppala, et al.. (2009). The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer — A prospective nation-wide study in Finland. Gynecologic Oncology. 115(2). 199–203. 28 indexed citations
5.
Komulainen, Marja, Heikki Kröger, Marjo Tuppurainen, et al.. (2008). HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas. 61(1-2). 85–94. 6 indexed citations
6.
Kuoppala, Tapio, Arto Leminen, Marja Komulainen, et al.. (2007). Surgical staging, treatment, and follow‐up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland. Acta Obstetricia Et Gynecologica Scandinavica. 86(5). 610–614. 13 indexed citations
7.
Heikkinen, Anna Maria, Leo Niskanen, Jukka A. Salmi, et al.. (2004). Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women. Bone. 35(3). 589–594. 9 indexed citations
8.
Heikkinen, Anna Maria, Anitta Mahonen, Heikki Kröger, et al.. (2003). Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women*. Annals of Medicine. 35(4). 282–288. 41 indexed citations
9.
Komulainen, Marja, Marjo Tuppurainen, & Heikki Kröger. (2003). [Bones are breaking without estrogen].. PubMed. 119(22). 2183–9.
10.
Heikkinen, Anna Maria, Anitta Mahonen, Heikki Kröger, et al.. (2002). Relation of estrogen receptor-α gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women. Annals of Medicine. 34(1). 64–72. 16 indexed citations
11.
Honkanen, Risto, et al.. (2001). Hormone replacement therapy and risk of falling in early postmenopausal women – a population‐based study. Clinical Endocrinology. 54(6). 769–774. 22 indexed citations
12.
Honkanen, R., Marja Komulainen, Heikki Kröger, et al.. (2001). Effect of calcium on bone loss and fractures according to estrogen repletion status.. 51–64. 2 indexed citations
13.
Komulainen, Marja, et al.. (2000). Identification of Early Postmenopausal Women with No Bone Response to HRT: Results of a Five-Year Clinical Trial. Osteoporosis International. 11(3). 211–218. 52 indexed citations
14.
Heikkinen, Anna Maria, Heikki Kröger, Leo Niskanen, et al.. (2000). Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?. Maturitas. 34(1). 33–41. 28 indexed citations
15.
Mahonen, Anitta, Heikki Kröger, Marja Komulainen, et al.. (2000). The Protective Effect of Hormone-Replacement Therapy on Fracture Risk Is Modulated by Estrogen Receptor α Genotype in Early Postmenopausal Women. Journal of Bone and Mineral Research. 15(12). 2479–2486. 55 indexed citations
16.
Mahonen, Anitta, et al.. (2000). Early Postmenopausal Bone Loss Is Associated with PvuII Estrogen Receptor Gene Polymorphism in Finnish Women: Effect of Hormone Replacement Therapy. Journal of Bone and Mineral Research. 15(2). 315–321. 86 indexed citations
17.
Komulainen, Marja, Heikki Kröger, Marjo Tuppurainen, et al.. (1999). Prevention of Femoral and Lumbar Bone Loss with Hormone Replacement Therapy and Vitamin D3in Early Postmenopausal Women: A Population-Based 5-Year Randomized Trial1. The Journal of Clinical Endocrinology & Metabolism. 84(2). 546–552. 90 indexed citations
18.
Komulainen, Marja, Heikki Kröger, Marjo Tuppurainen, et al.. (1998). HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas. 31(1). 45–54. 167 indexed citations
19.
Tuppurainen, M., et al.. (1997). Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. European Journal of Endocrinology. 137(5). 495–502. 85 indexed citations
20.
Komulainen, Marja, M. Tuppurainen, Heikki Kröger, et al.. (1997). Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study. Osteoporosis International. 7(2). 126–132. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmad Hazem Breakdown of academic impact, for papers by Lis Stilgren Breakdown of academic impact, for papers by Osamu Chaki Breakdown of academic impact, for papers by V Pacovský Breakdown of academic impact, for papers by Alan Hamstra Breakdown of academic impact, for papers by Ian Reid Breakdown of academic impact, for papers by Raymond Pamphile Breakdown of academic impact, for papers by Kazuya Makita Breakdown of academic impact, for papers by C. Hasling Breakdown of academic impact, for papers by Niva Jaccard
Rankless by CCL
2026